Published in Eur Arch Otorhinolaryngol on November 27, 2010
Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc (2006) 11.99
Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol (2008) 10.77
Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat Biotechnol (2005) 8.00
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J (2005) 4.91
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater (2008) 4.81
Multiple label-free biodetection and quantitative DNA-binding assays on a nanomechanical cantilever array. Proc Natl Acad Sci U S A (2002) 2.32
Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope (2006) 2.27
Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol (2005) 1.84
Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol (2006) 1.80
Oral cancer diagnosis by mechanical phenotyping. Cancer Res (2009) 1.70
A spectroscopic mechanism for primary olfactory reception. Chem Senses (1996) 1.63
Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol (2002) 1.63
Nano hemostat solution: immediate hemostasis at the nanoscale. Nanomedicine (2006) 1.34
Could humans recognize odor by phonon assisted tunneling? Phys Rev Lett (2007) 1.34
[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology (2005) 1.30
Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold. Nanomedicine (2007) 1.24
The cytoskeleton in cancer cells. Biochim Biophys Acta (1985) 1.22
Nanostructured polymer scaffolds for tissue engineering and regenerative medicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.15
Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord (2003) 1.11
Olfactory dysfunction in three neurodegenerative diseases. Geriatrics (1991) 1.02
Anosmia after intranasal zinc gluconate use. Am J Rhinol (2004) 1.02
Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles. Pharm Res (2009) 0.91
The mathematical engines of nanomedicine. Small (2008) 0.91
Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Nanomedicine (2010) 0.90
Recent advances in basic and clinical nanomedicine. Med Clin North Am (2007) 0.88
Biomarkers for the early detection of Parkinson's and Alzheimer's disease. Neurodegener Dis (2008) 0.88
Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine (2008) 0.86
Olfaction and olfactory epithelium in mice treated with zinc gluconate. Laryngoscope (2007) 0.86
Ultrafine particles in human lung macrophages. Arch Environ Health (2001) 0.85
Protecting new ideas and inventions in nanomedicine with patents. Nanomedicine (2005) 0.83
In vivo evaluation of chemical biopersistence of nonfibrous inorganic particles. Environ Health Perspect (1994) 0.83
Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine (Lond) (2009) 0.83
Science of nanofibrous scaffold fabrication: strategies for next generation tissue-engineering scaffolds. Nanomedicine (Lond) (2009) 0.83
Enhancement of odorant-induced responses in olfactory receptor neurons by zinc nanoparticles. Chem Senses (2009) 0.81
Clinical evaluation of the electronic nose in the diagnosis of ear, nose and throat infection: a preliminary study. J Laryngol Otol (2004) 0.81
Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Pak J Pharm Sci (2009) 0.81
Immunohistochemical studies of the cellular changes in the peripheral olfactory system after zinc sulfate nasal irrigation. Neurochem Res (2004) 0.80
From bench to bedside: successful translational nanomedicine: highlights of the Third Annual Meeting of the American Academy of Nanomedicine. Nanomedicine (2007) 0.80
Anosmia in Alzheimer disease. Percept Mot Skills (1994) 0.79
Nanostructures in biodefense and molecular diagnostics. Expert Rev Mol Diagn (2004) 0.78
Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B. Ther Clin Risk Manag (2007) 0.78
The emergence of nanomedicine: a field in the making. Nanomedicine (Lond) (2006) 0.78
Effect of zinc sulfate on sensorineural olfactory disorder. Acta Otolaryngol Suppl (1998) 0.77
Medical nanotechnology in the UK: a perspective from the London Centre for Nanotechnology. Nanomedicine (2006) 0.77
Theranostic proteomic profiling of cyclins, cyclin dependent kinases and Ras in human cancer cell lines is dependent on p53 mutational status. Int J Oncol (2008) 0.77
Proteomics blood testing to distinguish chronic rhinosinusitis subtypes. Laryngoscope (2008) 0.76
Photoactivated enediynes as targeted antitumoral agents: efficient routes to antibody and gold nanoparticle conjugates. Bioorg Med Chem Lett (2008) 0.76
Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection. J Neural Transm Suppl (2006) 0.75
Cell- and tissue-engineered organ replacements. Br J Surg (2009) 0.75
Call from China for joint nanotech toxicity-testing effort. Nature (2009) 0.75
Launch of the London Centre for Nanotechnology. Nanomedicine (Lond) (2006) 0.75
Capsule endoscopy. BMJ (2009) 0.75
[Relationship between the regional cerebral blood flow and the cognitive function and anosmia in patients with Parkinson disease and Alzheimer disease]. Brain Nerve (2009) 0.75
Nanomedicine: important new concepts for otolaryngology. Ear Nose Throat J (2007) 0.75